ArticleHormones (Athens, Greece)2025
Exploring the role of hemodilution in the inverse association between obesity and testosterone concentrations in men.
Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study aims to explore the inverse correlation between obesity and testosterone concentrations in men, with a particular focus on the role of hemodilution in this association. The research question addressed is whether hemodilution, due to increased plasma volume (PV), contributes to the lower testosterone concentrations observed in obese men.
methodsWe conducted a retrospective analysis using three datasets with sample sizes of 86, 134, and 446 participants, respectively. Multivariable linear regression models were used to examine the changes in PV, testosterone concentration, and mass across BMI categories, adjusting for age in each dataset and in the pooled data.
resultsThe study demonstrated a significant inverse correlation between BMI groups and testosterone concentrations across the three datasets, as well as in the pooled data (beta coefficients: -0.024, -0.045, -0.040, -0.043; P < 0.001). Despite this, total testosterone mass remained stable (P > 0.05), suggesting that hemodilution, rather than a reduction in testosterone production, may account for the lower testosterone concentrations in obesity. Adjusted testosterone concentrations for obese participants were calculated using a formula that accounts for the increased PV.
conclusionOur findings suggest that hemodilution, associated with increased PV in obesity, is a significant factor contributing to the lower testosterone concentrations in obese men. This has implications for the diagnosis and treatment of testosterone deficiency in obesity and underscores the need for adjusted reference ranges. Further research is necessary to validate these findings and to explore their clinical implications.
Indexed as
Identifiers
40249461What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.